AGENDA

11:30 a.m. – 12:00 p.m.

Registration & Networking (The Grove)

12:00 – 12:10 p.m.

Welcome (Gallery Ballroom)
Allison Spinner, Partner, Wilson Sonsini

12:10 – 1:00 p.m.

Lunch and Keynote (Gallery Ballroom)
Sebastian Thrun, Former Google X

Sebastian Thrun is a pioneering AI researcher and entrepreneur who led Stanford’s team behind Stanley, the robotic vehicle that won the 2005 DARPA Grand Challenge, helping lay the foundation for the autonomous vehicle industry. He later joined Google, where he co-founded Google X and helped launch projects such as Waymo’s self-driving cars, Google Glass, and Google Street View. In 2012, he co-founded Udacity, which reached over 21 million learners before its 2024 acquisition by Accenture, and also launched ventures including Kitty Hawk and Crossing Minds. Now CEO of Sage AI Labs and co-founder and chairman of Cresta, Thrun remains an influential force in AI, robotics, and education, earning honors such as election to the National Academy of Engineering at age 39.

1:00 – 2:00 p.m.

Market Overview
Receive an insider’s view of the current state of the capital markets and an exploration of potential paths to market “normalcy.” What are the markers for an improved environment for technology and life sciences IPOs? Do any recent IPOs enlighten the way forward, both in terms of market conditions and post-IPO performance expectations? How do market trends and conditions affect your IPO timeline?

Tech Track (Grand West Ballroom)

Moderator:
Lianna Whittleton, Partner, Wilson Sonsini

Panelists:
Diana Doyle, Head of Technology Equity and Equity-Linked Capital Markets, Americas, Morgan Stanley
Bill Koefoed, Senior Advisor, OneStream

Life Sciences Track (Grand East Ballroom)

Moderator:
Mike Nordtvedt, Partner, Wilson Sonsini

Panelist:
Hirsh Shukla, Managing Director, Healthcare Investment Banking, Goldman Sachs

2:00 – 2:15 p.m.

Networking Break (Grand Promenade/Grove)

2:15 – 3:00 p.m.

Tech Track | Preparing for Success: Understanding Dual-Class Structures, the Alternatives, and Important Trends in Post-IPO Corporate Governance (Grand West Ballroom)
Many innovative companies will want to consider whether to implement a dual/multi-class stock structure in connection with an IPO and place voting control with a particular group of stockholders.  In this session, we will discuss the purpose, benefits, and tradeoffs of such a structure and the alternatives.  We will also discuss related corporate governance topics for any newly public company post-IPO, including stockholder activism, the stockholder litigation landscape, and the burgeoning debate about whether companies should continue to incorporate in Delaware.

Presenters:
Amy Simmerman, Partner, Wilson Sonsini
Marty Korman, Partner, Wilson Sonsini

Life Sciences Track | Investor Perspectives (Grand East Ballroom)
In this discussion, seasoned public/private investors share their views on the IPO process and how it has evolved in the life science industry over the years.  The panel will discuss cross-over financings, banker selection, inside investor participation and allocation of IPO shares, along with post-IPO trading dynamics and support. Expect insights that help C-suite leaders navigate the investor expectations on the path to a successful IPO.

Moderator:
Dan Koeppen, Partner, Wilson Sonsini

Panelist:
Chris Chai, Venture Partner, SR One
Zach Scheiner, PhD, Partner, RA Capital

3:00 – 3:30 p.m.

Networking Break (Grand Promenade/Grove)

3:30 – 6:30 p.m.

Afternoon Activities

• A Bee’s Journey
• Bike & Hike Healdsburg
• Hands on Culinary Studio
• Master Photography Class at Aperture Cellars
• Montage Signature Facial
• Pickleball
• Sonoma Blend Massage

7:00 – 8:00 p.m.

Wine Tasting Reception (Grand Lawn)

8:00 – 9:30 p.m.

Dinner (Grand Lawn)

9:30 – 10:30 p.m.

After Dinner Drinks (Scout Field Bar)

8:00 – 8:45 a.m.

Drop-In Breakfast (The Grove)

9:00 – 10:00 a.m.

Fireside Chat with Stacey Cunningham (Gallery Ballroom)
Stacey Cunningham is the former President of NYSE Group, which includes the New York Stock Exchange, the world’s largest equity exchange and premier venue for capital raising. She was the NYSE’s 67th President and first woman to lead the Exchange in its over 230-year history. Prior to being named NYSE President, Cunningham served as NYSE Chief Operating Officer and has held several senior positions at global exchanges.

Currently, Cunningham is a member of the Boards of Directors of the New York Stock Exchange and Cloudflare (NYSE: NET), a global cloud services provider, as well as the Board of Advisors of Georgetown University’s Psaros Center for Financial Markets and Policy. Additionally, she serves as an advisor for private companies and as an Operating Partner for Advent, a global private equity firm. She has a degree in Industrial Engineering from Lehigh University and previously served on the Boards of Catalyst and the Partnership for New York City.

Moderator:
Megan Baier, Partner, Wilson Sonsini

10:00 – 10:15 a.m.

Networking Break (Grand Promenade/Grove)

10:15 – 11:45 a.m.

Tech Track | Executive Perspectives: “What Really Matters?” (Grand West Ballroom)
The roadmap to filing a successful IPO can be challenging, and understanding all the nuances can be overwhelming.  Our seasoned executives will share their personal insights from their own IPO journeys and identify what really matters most.

Moderator:
Rezwan Pavri, Partner, Wilson Sonsini

Panelists:
Adam Frankel, GC & Corporate Secretary, Chime
Ryan Taylor, Chief Revenue Officer and Chief Legal Officer, Palantir

Life Sciences Track | Fireside Chat with Raju Mohan, PhD, Ventyx Biosciences (Grand East Ballroom)
Life sciences companies confront unique challenges on their path from a late-stage private company to the public markets and beyond—from scientific inflection points and capital-market volatility to competitive positioning, complex regulatory and commercialization considerations. In this candid conversation, Raju Mohan, CEO of Ventyx Biosciences, will share an insider’s perspective on building and leading one of the standout immunology companies in recent years through its IPO and its recent strategic exit.  Raju will discuss pivotal decisions, turning points, and operational disciplines that shaped the Ventyx trajectory, including what he wishes he had known earlier, what surprised him most about the transition from private to public, and how leaders can best prepare their organizations for scrutiny, scale, and optionality.

Moderator:
Tony Jeffries, Partner, Wilson Sonsini

Presenter:
Raju Mohan, PhD, Founder, CEO & Director, Ventyx Biosciences

11:45 a.m. – 12:00 p.m.

Closing Remarks

12:00 p.m.

Lunch and Departures (The Grove)